x
ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2015 > ESO Masterclass in Clinical Oncology
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Description

Chairs: N. Pavlidis, GR - D. Zaridze, RU
Host Chair : R. Gvamichava, GE


AIMS AND OBJECTIVES
This clinically oriented residential educational programme has been designed for dedicated physicians wishing to improve their skills in the management of cancer patients.
The Masterclass is dedicated to clinicians who are specifically and almost exclusively dedicated to clinical oncology. This programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on breast, colorectal and lung cancers.


TEACHING FORMAT
The Masterclass offers plenary lectures regarding the-state-of the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages. Furthermore, practical training will be offered in the frame of clinical case discussion sessions. Participants will deliver case presentations after each session and discuss these with the faculty and the audience .
Participation is compulsory throughout the event. The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.

THE MASTERCLASS IS
• Full immersion
• Clinically-oriented
• Multidisciplinary
• Delivered by an international faculty of experts


LANGUAGE
The Masterclass will be held in English and translation will not be provided.

Faculty list

 

FACULTY
S. Cascinu, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, IT
G. Ceresoli
, Humanitas Gavazzeni, Bergamo, IT
R. Gagua, National Cancer Centre, Tbilisi, GE
F. Geara, American University of Beirut, LB
R. Gvamichava, National Screening Centre, Tbilisi, GE
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
N. Pavlidis, University Hospital of Ioannina, GR
M. Rosselli Del Turco, Centres for Cancer Studies and Prevention, Screening Unit, Florence, IT
E. Senkus-Konefka, Medical University of Gdansk, PL
N. Sharikadze, National Cancer Centre, Tbilisi, GE
D. Tabagari, National Cancer Centre, Tbilisi, GE
T. Wiggers, University Medical Centre Groningen, NL
D. Zaridze, N.N. Blokhin Cancer Research Center, Moscow, RU

Programme

 28 October

   

  9:00

 

Welcome address
R. Gvamichava, GE - N. Pavlidis, GR - D. Zaridze, RU

9:15

 

Epidemiology and prevention
D. Zaridze, RU

 

 

BREAST CANCER
Chair: N. Pavlidis, GR - D. Tabagari, GE

10:00

 

Screening of breast cancer
M. Rosselli Del Turco, IT

10.30
 

Radiotherapy of breast cancer
F. Geara, LB

11:00 

Coffee break

 11:30 

Neoadjuvant and adjuvant chemotherapy and biological treatment
O. Pagani, CH

 12:00 

Neoadjuvant and adjuvant endocrine treatment
O. Pagani, CH

 12:30 

Case presentations and discussion
(4 cases presented by participants)

Panelists: N. Pavlidis, GR (Moderator) - O. Pagani, CH - F. Geara, LB

 13:30 

Lunch

  

BREAST CANCER
Chairs: O. Pagani, CH - N. Sharikadze, GE

 14:45 

Management of HER-2 positive and triple negative advanced disease
E. Senkus-Konefka, PL

15:15 

Management of ER positive advanced breast cancer 
E. Senkus-Konefka, PL

15:45 

Coffee break

 16:15 

Case presentations and discussion (4 cases presented by participants)
Panelists: N. Pavlidis, GR (Moderator) - E. Senkus-Konefka, PL - F. Geara, LB

 17:15 

End of daily programme

 19:30 

Dinner

 

 29 October


  

COLORECTAL CANCER
Chairs: T. Wiggers, NL - R. Gvamichava, GE

9:00 

Adjuvant and neoadjuvant systemic treatment
S. Cascinu, IT

9:45
 

Systemic treatment in advanced disease
S. Cascinu, IT

10:30
 

Combined treatment of colorectal cancer
T. Wiggers, NL

11:15 

Coffee break

11:45
 

Case presentations and discussion (4 cases presented by participants)
Panelists: N. Pavlidis, GR (Moderator) - T. Wiggers, NL - S. Cascinu, IT

12:45 

Lunch

  

LUNG CANCER
Chairs: G. Ceresoli, IT - R. Gagua, GE

14:00
 

Radiotherapy of lung cancer
F. Geara, LB

14:45
 

Systemic treatment (chemotherapy and targeting therapy) of NSCLC
G. Ceresoli, IT

15:30
 

Systemic treatment of SCLC
G. Ceresoli, IT

16:00
 

Coffee break

16:30
 

Case presentations and discussion (4 cases presented by participants)
Panelists: N. Pavlidis, GR (Moderator) - G. Ceresoli, IT - F. Geara, LB

17:30
 

Closing remarks

19:30
 

Dinner